Vascular endothelial growth factor: The major factor for tumor neovascularization and edema formation in meningioma patients

Neurosurgery

Volumn 67, Issue 6, 2010, Pages 1703-1708

  Schmid, Sabine ^a   Aboul Enein, Fahmy ^a   Pfisterer, Wolfgang ^a   Birkner, Thomas ^b   Stadek, Christian ^a   Knosp, Engelbert ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b NONE   (Austria)

Author keywords

Edema; Immunohistochemistry; Magnetic resonance imaging; Meningioma; Vascular endothelial growth factor; Vascular supply

Indexed keywords

KI 67 ANTIGEN; VASCULOTROPIN;

ADULT; ARTICLE; BRAIN EDEMA; CANCER GRADING; CANCER SIZE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTRAOPERATIVE PERIOD; MAJOR CLINICAL STUDY; MALE; MALIGNANT MENINGIOMA; NEOVASCULARIZATION (PATHOLOGY); NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PERITUMORAL BRAIN EDEMA; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR NEOVASCULARIZATION; TUMOR VOLUME; VASCULARIZATION; WORLD HEALTH ORGANIZATION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BRAIN EDEMA; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MENINGEAL NEOPLASMS; MENINGIOMA; MIDDLE AGED; NEOVASCULARIZATION, PATHOLOGIC; REGRESSION ANALYSIS; STATISTICS, NONPARAMETRIC; VASCULAR ENDOTHELIAL GROWTH FACTOR A; YOUNG ADULT;

EID: 78650475891     PISSN: 0148396X     EISSN: None     Source Type: Journal    
DOI: 10.1227/NEU.0b013e3181fb801b     Document Type: Article

References (34)

1. Senger DR, Galli SJ, Dvorak AM, Perruzzi CA, Harvey VS, Dvorak HF. Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. Science. 1983;219(4587):983-985.
2. Breier G, Albrecht U, Sterrer S, Risau W. Expression of vascular endothelial growth factor during embryonic angiogenesis and endothelial cell differentiation. Development. 1992;114(2):521-532.
3. Jacobi J, Tam BY, Sundram U, et al. Discordant effects of a soluble VEGF receptor on wound healing and angiogenesis. Gene Ther. 2004;11(3):302-309.
4. Rogers PA, Gargett CE. Endometrial angiogenesis. Angiogenesis. 1998;2:287-294.
5. Fischer I, Gagner JP, Law M, Newcomb EW, Zagzag D. Angiogenesis in gliomas: biology and molecular pathophysiology. Brain Pathol, 2005, 15(4) 297-310.
6. GreenbergDA, Jin K. From angiogenesis to neuropathology. Nature. 2005;438:954-959.
7. Huang H, Held-Feindt J, Buhl R,Mehdorn HM, Mentlein R. Expression of VEGF and its receptors in different brain tumors. Neurol Res. 2005;27(4):371-377.
8. Marti HJ, Bernaudin M, Bellail A, et al. Hypoxia-induced vascular endothelial growth factor expression precedes neovascularization after cerebral ischemia. Am J Pathol. 2000;156(3):965-976.
9. Merrill MJ, Oldfield EH. A reassessment of vascular endothelial growth factor in central nervous system pathology. J Neurosurg. 2005;103(5):853-868.
10. Aboul-Enein F, Rauschka H, Kornek B, et al. Preferential loss of myelin-associated glycoprotein reflects hypoxia-like white matter damage in stroke and inflammatory brain diseases. J Neuropathol Exp Neurol. 2003;62(1):25-33.
11. Goldman CK, Bharara S, Palmer CA, et al. Brain edema in meningiomas is associated with increased vascular endothelial growth factor expression. Neurosurgery. 1997;40(6):1269-1277.
12. Zhang Y, Matsuo H, Morita E. Vascular endothelial growth factor 121 is the predominant isoform in psoriatic scales. Exp Dermatol. 2005;14(10):758-764.
13. Lantos P, Louis D, Rosenblum M, Kleihues P. Greenfield́s Neuropathology Illustrated. 7th ed. London, UK: Arnold (Hodder Headline Group), 2002, pp 909-930
14. Louis DN, Scheithauer BW, Budka H, von Deimling A, Kepes JJ. Pathology and Genetics of Tumours of the Nervous System: World Health Organisation Classification of Tumours. Lyon, France: IARC Press; 2000:176-184.
15. Jaaskelainen J, Haltia M, Servo A. Atypical and anaplastic meningiomas: radiology, surgery, radiotherapy, and outcome. Surg Neurol. 1986;25(3):233-242.
16. Bitzer M, Topka H, Morgalla M, Friese S, Wockel L, Voigt K. Tumor-related venous obstruction and development of peritumoral brain edema in meningiomas. Neurosurgery. 1998;42(4):730-737.
17. Bitzer M, Wockel L, Morgalla M, et al. Peritumoural brain oedema in intracranial meningiomas: influence of tumour size, location and histology. Acta Neurochir (Wien). 1997;139(12):1136-1142.
18. Lobato RD, Alday R, Gomez PA, et al. Brain oedema in patients with intracranial meningioma. Correlation between clinical, radiological, and histological factors and the presence and intensity of oedema. Acta Neurochir (Wien). 1996;138(5):485-493.
19. Abe T, Black PM, Ojemann RG, Hedley-White ET. Cerebral edema in intracranial meningiomas: evidence for local and diffuse patterns and factors associated with its occurrence. Surg Neurol. 1994;42(6):471-475.
20. Bitzer M, Opitz H, Popp J, et al. Angiogenesis and brain oedema in intracranial meningiomas: influence of vascular endothelial growth factor. Acta Neurochir (Wien). 1998;140(4):333-340.
21. Kalkanis SN, Carroll RS, Zhang J, Zamani AA, Black PM. Correlation of vascular endothelial growth factor messenger RNA expression with peritumoral vasogenic cerebral edema in meningiomas. J Neurosurg. 1996;85(6):1095-1101.
22. Aboul-Enein F, Weiser P, Hoftberger R, Lassmann H, Bradl M. Transient axonal injury in the absence of demyelination: a correlate of clinical disease in acute experimental autoimmune encephalomyelitis. Acta Neuropathol. 2006;111(6): 539-547.
23. Aboul-Enein F, Höftberger R, Buxhofer-Ausch V, et al. Neocortical neurones may be targeted by immune attack in anti-Yo paraneoplastic syndrome. Neuropathol Appl Neurobiol. 2008;34(2):248-252.
24. Kujas M. Meningioma.Curr Opin Neurol. 1993;6:882-887.
25. Paek SH, Kim CY, Kim YY, et al. Correlation of clinical and biological parameters with peritumoral edema in meningioma. J Neurooncol. 2002;60(3):235-245.
26. Sanson M, Cornu P. Biology of meningiomas. Acta Neurochir (Wien). 2000;142:493-505.
27. Wilson CB. Meningiomas: genetics, malignancy, and the role of radiation in induction and treatment. The Richard C. Schneider Lecture. J Neurosurg. 1994;81(5):666-675.
28. Nishikawa R, Cheng SY, Nagashima R, Huang HJ, Cavenee WK, Matsutani M. Expression of vascular endothelial growth factor in human brain tumors. Acta Neuropathol (Berl). 1998;96(5):453-462.
29. Tsai JC, Hsiao YY, Teng LJ, et al. Regulation of vascular endothelial growth factor secretion in human meningioma cells. J Formos Med Assoc. 1999;98(2):111-117.
30. Yoshioka H, Hama S, Taniguchi E, Sugiyama K, Arita K, Kurisu K. Peritumoral brain edema associated with meningioma: influence of vascular endothelial growth factor expression and vascular blood supply. Cancer. 1999;85(4):936-944.
31. Bitzer M, Wockel L, Luft AR, et al. The importance of pial blood supply to the development of peritumoral brain edema in meningiomas. J Neurosurg. 1997;87(3):368-373.
32. de Vries C, Escobedo JA, Ueno H, Houck K, Ferrara N, Williams LT. The fmslike tyrosine kinase, a receptor for vascular endothelial growth factor. Science. 1992;255:989-991.
33. Prewett M, Huber J, Li Y, et al. Antivascular endothelial growth factor receptor (fetal liver kinase 1) monoclonal antibody inhibits tumor angiogenesis and growth of several mouse and human tumors. Cancer Res. 1999;59(20):5209-5218.
34. Terman BI, Carrion ME, Kovacs E, Rasmussen BA, Eddy RL, Shows TB. Identification of a new endothelial cell growth factor receptor tyrosine kinase. Oncogene. 1991;6(9):1677-1683.